Health Care

Biotech companies all over the world have been trying to find the treatment and vaccine for the coronavirus pandemic since…

10x Genomics, Inc.  (NASDAQ: TXG) Q4 2019 Earnings Conference Call Final Transcript CORPORATE PARTICIPANTS: Carrie Mendivil -- Investor Relations Serge Saxonov -- Chief Executive Officer,…

Veru Inc.  (NASDAQ: VERU) Q1 2020 Earnings Conference Call Final Transcript CORPORATE PARTICIPANTS: Sam Fisch -- Director of Investor Relations Mitchell S. Steiner -- Chairman,…

Align Technology Inc. (NASDAQ: ALGN) stock plunged to a 3-year low of $161.39 on Monday as the global pandemic overshadowed…

-- Catalyst Pharmaceutical (NASDAQ: CPRX) reported its fourth-quarter 2019 earnings of $0.07 per share versus $0.10 per share expected. --…

-- CorMedix Inc. (NYSE: CRMD) reported a fourth-quarter 2019 loss of $0.21 per share versus a loss of $0.24 per…

-- Specialty pharmaceutical company AcelRx Pharmaceuticals (NASDAQ: ACRX) reported fourth quarter 2019 loss of $0.18 per share vs. expected loss of…

-- Achieve Life Sciences (NASDAQ: ACHV) reported Q4 2019 net loss of $3.2 million, or $0.30 per share, compared to…

-- Neos Therapeutics Inc. (NASDAQ: NEOS) reported a fourth-quarter 2019 loss of $0.07 per share versus a loss of $0.03…

For some of the leading drugmakers, currently, the first priority is to find an effective treatment for Covid-19, which was…

-- Biopharmaceutical company Dynavax Technologies Corporation (NASDAQ: DVAX) reported a net loss of $36.8 million $0.44 per share for the…

Novavax Inc. (NASDAQ: NVAX) reported a narrower loss for the fourth quarter of 2019 helped by higher revenue and lower…

PetIQ, Inc.  (NASDAQ: PETQ) Q4 2019 Earnings Conference Call Final Transcript Corporate Participants: Jeff Sonnek -- Senior Vice President, ICR McCord Christensen -- Chief Executive…

-- Avid Bioservices (NASDAQ: CDMO) reported a loss of $0.## per share for its third quarter of 2020 vs. expected…

Image for representation (Photo by Drew Hays on Unsplash) — Sunesis Pharmaceuticals (NASDAQ: SNSS) reported loss of $0.05 per share in the…

-- Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) reported a net loss of $6.6 million or $0.55 per share for the fourth…

InspireMD Inc. (NYSE: NSPR) reported earnings that matched expectations for the fourth quarter of 2019 while revenues missed estimates. The…

-- Akebia Therapeutics (NASDAQ: AKBA) reported fourth quarter 2019 loss of $0.79 per share vs. expected loss of $0.47 per…

-- Minerva Neurosciences Inc. (NASDAQ: NERV) reported a fourth-quarter 2019 loss of $29.9 million or $0.77 per share, wider than…

BioXcel Therapeutics, Inc. (NASDAQ: BTAI) reported a wider net loss for the fourth quarter, owing to an increase in research…

Image for representation (Photo by Drew Hays on Unsplash) — Matinas BioPharma (NYSE: MTNB) reported loss of $0.04 per share in the…